When to Retest After STD Treatment

Retesting after STD treatment is not optional — it's a clinical standard that detects reinfection, confirms treatment success where needed, and prevents further transmission. The CDC recommends retesting for chlamydia and gonorrhea 3 months after treatment regardless of symptoms; syphilis requires RPR titer monitoring at 6 and 12 months post-treatment; HIV-positive people retest on a schedule set by their specialist; and reinfection — not treatment failure — is the most common reason a positive test follows a treated infection.

Why Retesting Is Necessary Even After Successful Treatment

The most common reason STD-positive people test positive again after treatment is reinfection, not treatment failure. Reinfection occurs when: an untreated partner reinfects the treated person (the most common scenario — particularly with chlamydia and trichomoniasis where partner treatment is frequently incomplete); a new exposure occurs in the months following treatment; or a concurrent infection at a different anatomical site wasn't detected or treated during the initial episode. Studies show that approximately 20% of people treated for chlamydia test positive again within 3 to 4 months — almost entirely due to reinfection rather than treatment failure. This reinfection rate is precisely why retesting at 3 months is clinically recommended regardless of symptoms.

Chlamydia: Retest at 3 Months

The CDC's standard recommendation for chlamydia: retest 3 months after completing treatment. This timing reflects peak reinfection risk rather than test-of-cure. By 3 months, a new exposure from an untreated partner or a new partner would be detectable by NAAT. A test of cure (retesting 4 weeks after treatment to confirm the bacteria is gone) is not routinely recommended for chlamydia in non-pregnant individuals, because doxycycline and azithromycin have documented cure rates over 97%, and dead bacterial DNA can cause a false positive on NAAT if tested too soon after treatment (the assay detects DNA, not live bacteria). Test-of-cure exceptions: pregnancy (retest 4 weeks after treatment and again at 3 months); if symptoms persist after treatment (suggests treatment failure or reinfection); if azithromycin was used (lower cure rates in some populations — doxycycline is now preferred).

Gonorrhea: Test of Cure for Pharyngeal Infection, Retest at 3 Months

Gonorrhea management differs from chlamydia in one important way: test of cure (TOC) is recommended for pharyngeal gonorrhea specifically. Pharyngeal gonorrhea has lower cure rates than urogenital gonorrhea even with ceftriaxone — studies show pharyngeal cure rates of approximately 80 to 90% vs. over 99% for urogenital sites. The CDC recommends a test of cure at 7 to 14 days after treatment for pharyngeal gonorrhea. For urogenital and rectal gonorrhea: test of cure is not routinely required if treated with ceftriaxone 500mg IM. Retest at 3 months for all sites regardless of symptoms, for the same reinfection detection reason as chlamydia.

Syphilis: RPR Titer Monitoring

Syphilis follow-up is titer-based rather than simple positive/negative retesting. After treatment with benzathine penicillin G: retest RPR at 6 months and 12 months post-treatment. Expected response: RPR titer should decline at least 4-fold within 12 months of treatment (e.g., from 1:16 to 1:4). A 4-fold decline confirms adequate treatment response. Failure to decline 4-fold at 12 months may indicate: treatment failure (uncommon with benzathine penicillin G); reinfection; neurosyphilis (which requires IV penicillin rather than IM). Serofast syphilis: some people maintain a low, stable RPR titer (typically 1:4 or lower) indefinitely after treated syphilis — this is not treatment failure but a residual immunological response. Treponemal tests (TPPA, FTA-ABS) remain positive for life after any syphilis infection and are not useful for monitoring treatment response. Only RPR/VDRL titers are used for treatment monitoring.

HIV: Ongoing Monitoring on Specialist Schedule

For people newly diagnosed with HIV and starting ART: viral load testing at 2 to 4 weeks after starting ART, then at 4 to 8 weeks, then every 3 to 6 months once stable. CD4 count monitoring every 3 to 6 months initially, then annually when stable and CD4 above 300. STD screening for HIV-positive people: quarterly gonorrhea, chlamydia, and syphilis screening for sexually active HIV-positive individuals — because STDs facilitate HIV transmission and HIV infection significantly complicates STD management. Annual HIV testing is recommended for all high-risk individuals even before diagnosis; this schedule changes to monitoring after diagnosis.

Trichomoniasis: Retest at 3 Months

Trichomoniasis has the highest reinfection rate of any common STD — approximately 20% of treated patients test positive again within 3 months, almost entirely due to untreated partners. The CDC recommends retesting at 3 months after treatment. Both partners must be treated simultaneously to prevent reinfection; expedited partner therapy (EPT) exists specifically for this purpose. If symptoms return after treatment before the 3-month retest: retest immediately — persistent symptoms suggest either treatment failure (metronidazole resistance is rare but documented) or reinfection from an untreated partner.

Herpes: No Standard Retesting Schedule

Herpes doesn't have a standard "retest after treatment" protocol because herpes is not curable — antiviral therapy suppresses replication but doesn't clear the virus. After diagnosis: the focus is on management (suppressive vs. episodic therapy decision) and transmission risk reduction, not follow-up testing for clearance. If herpes was diagnosed by IgG blood test with a low-positive index value (1.1 to 3.5): confirmatory testing (Biokit HSV-2 or Western blot) is recommended before accepting the diagnosis and committing to a management plan — because 48% of low-positive HerpeSelect results are false positives.

For private STD retesting with results in 1 to 2 days, Health Test Express offers panels without a GP referral.

When to Seek Evaluation Before the Scheduled Retest

Don't wait for the 3-month retest if: symptoms return or persist after treatment (possible treatment failure or reinfection); a partner notifies you of a positive test after you were both supposedly treated; you have a new high-risk exposure; you have pelvic pain, fever, or unusual discharge following treatment for gonorrhea or chlamydia (possible PID developing despite treatment).

Frequently Asked Questions

How long after chlamydia treatment should I wait to retest?

For routine reinfection screening: 3 months after treatment. Don't retest at 4 weeks as a test of cure — NAAT can detect dead bacterial DNA after treatment and produce a false positive. The 3-month recommendation is specifically calibrated to detect reinfection, not confirm cure (which the treatment's documented efficacy already achieves).

What if my STD test is positive again after treatment?

Positive retesting after confirmed treatment almost always means reinfection — particularly if a partner was not treated simultaneously. Less commonly, it may indicate a treatment failure (more likely with azithromycin for chlamydia, or oral antibiotics for gonorrhea). Retreat with the appropriate regimen and ensure all partners are treated. If repeated treatment failures occur, consider antibiotic resistance testing.

Do I need to retest after herpes treatment?

Not for viral clearance — herpes is not curable. If you're on suppressive antiviral therapy, there's no test-of-cure because the virus remains latent. If your original diagnosis was based on blood testing with a low index value, confirmatory testing before committing to a lifetime management plan is appropriate and is different from retesting after treatment.

Can I have sex after STD treatment before my retest?

For bacterial STDs (chlamydia, gonorrhea, syphilis, trichomoniasis): no sexual contact for 7 days after completing treatment AND until all partners have been treated. After that, sex is permitted but the 3-month retest should still be completed regardless of symptoms to detect reinfection. Using condoms in the interim reduces reinfection risk.

Related: Positive STD test: what to do · Doxycycline for chlamydia · False positive STD test · Trichomoniasis window period · Get tested today

This article is for informational purposes only and does not constitute medical advice.